Search

Your search keyword '"MARINOV, LYUBOMIR"' showing total 43 results

Search Constraints

Start Over You searched for: Author "MARINOV, LYUBOMIR" Remove constraint Author: "MARINOV, LYUBOMIR"
43 results on '"MARINOV, LYUBOMIR"'

Search Results

4. Figure 4 from: Marinov L, Georgieva A, Toshkova R, Kostadinova I, Mangarov I, Toshkova-Yotova T, Nikolova I (2024) The effects of meloxicam, lornoxicam, ketoprofen, and dexketoprofen on human cervical, colorectal, and mammary carcinoma cell lines. Pharmacia 71: 1-12. https://doi.org/10.3897/pharmacia.71.e113677

5. Figure 1 from: Marinov L, Georgieva A, Toshkova R, Kostadinova I, Mangarov I, Toshkova-Yotova T, Nikolova I (2024) The effects of meloxicam, lornoxicam, ketoprofen, and dexketoprofen on human cervical, colorectal, and mammary carcinoma cell lines. Pharmacia 71: 1-12. https://doi.org/10.3897/pharmacia.71.e113677

6. Figure 2 from: Marinov L, Georgieva A, Toshkova R, Kostadinova I, Mangarov I, Toshkova-Yotova T, Nikolova I (2024) The effects of meloxicam, lornoxicam, ketoprofen, and dexketoprofen on human cervical, colorectal, and mammary carcinoma cell lines. Pharmacia 71: 1-12. https://doi.org/10.3897/pharmacia.71.e113677

8. Figure 3 from: Marinov L, Georgieva A, Toshkova R, Kostadinova I, Mangarov I, Toshkova-Yotova T, Nikolova I (2024) The effects of meloxicam, lornoxicam, ketoprofen, and dexketoprofen on human cervical, colorectal, and mammary carcinoma cell lines. Pharmacia 71: 1-12. https://doi.org/10.3897/pharmacia.71.e113677

9. Supplementary material 1 from: Voynikov Y, Gevrenova R, Zheleva-Dimitrova D, Balabanova V, Nikolova I, Marinov L, Benbassat I, Momekov G (2023) UHPLC-Orbitrap screening of oleraindoles in hydromethanolic extracts of Portulaca oleracea. Pharmacia 70(4): 1521-1527. https://doi.org/10.3897/pharmacia.70.e113577

10. Figure 1 from: Petrova A, Simeonova R, Voycheva C, Savov Y, Marinov L, Balabanova V, Gevrenova R, Zheleva-Dimitrova D (2023) Metabolic syndrome: comparison of three diet-induced experimental models. Pharmacia 70(4): 1539-1548. https://doi.org/10.3897/pharmacia.70.e109965

11. Figure 5 from: Petrova A, Simeonova R, Voycheva C, Savov Y, Marinov L, Balabanova V, Gevrenova R, Zheleva-Dimitrova D (2023) Metabolic syndrome: comparison of three diet-induced experimental models. Pharmacia 70(4): 1539-1548. https://doi.org/10.3897/pharmacia.70.e109965

12. Figure 6 from: Petrova A, Simeonova R, Voycheva C, Savov Y, Marinov L, Balabanova V, Gevrenova R, Zheleva-Dimitrova D (2023) Metabolic syndrome: comparison of three diet-induced experimental models. Pharmacia 70(4): 1539-1548. https://doi.org/10.3897/pharmacia.70.e109965

13. Figure 4 from: Petrova A, Simeonova R, Voycheva C, Savov Y, Marinov L, Balabanova V, Gevrenova R, Zheleva-Dimitrova D (2023) Metabolic syndrome: comparison of three diet-induced experimental models. Pharmacia 70(4): 1539-1548. https://doi.org/10.3897/pharmacia.70.e109965

14. Figure 2 from: Petrova A, Simeonova R, Voycheva C, Savov Y, Marinov L, Balabanova V, Gevrenova R, Zheleva-Dimitrova D (2023) Metabolic syndrome: comparison of three diet-induced experimental models. Pharmacia 70(4): 1539-1548. https://doi.org/10.3897/pharmacia.70.e109965

15. Figure 3 from: Petrova A, Simeonova R, Voycheva C, Savov Y, Marinov L, Balabanova V, Gevrenova R, Zheleva-Dimitrova D (2023) Metabolic syndrome: comparison of three diet-induced experimental models. Pharmacia 70(4): 1539-1548. https://doi.org/10.3897/pharmacia.70.e109965

18. Figure 2 from: Kostadinova I, Danchev N, Landzhov B, Tsvetkova D, Marinov L, Ivanova I (2023) Creatine lysinate – part II: effects on the motor coordination and muscle hypertrophy in mice. Pharmacia 70(4): 967-972. https://doi.org/10.3897/pharmacia.70.e110718

20. Figure 1 from: Kostadinova I, Danchev N, Landzhov B, Tsvetkova D, Marinov L, Ivanova I (2023) Creatine lysinate – part II: effects on the motor coordination and muscle hypertrophy in mice. Pharmacia 70(4): 967-972. https://doi.org/10.3897/pharmacia.70.e110718

21. Figure 3 from: Kostadinova I, Danchev N, Landzhov B, Tsvetkova D, Marinov L, Ivanova I (2023) Creatine lysinate – part II: effects on the motor coordination and muscle hypertrophy in mice. Pharmacia 70(4): 967-972. https://doi.org/10.3897/pharmacia.70.e110718

22. Figure 4 from: Kostadinova I, Danchev N, Landzhov B, Tsvetkova D, Marinov L, Ivanova I (2023) Creatine lysinate – part II: effects on the motor coordination and muscle hypertrophy in mice. Pharmacia 70(4): 967-972. https://doi.org/10.3897/pharmacia.70.e110718

24. Figure 1 from: Kostadinova I, Danchev N, Landzhov B, Marinov L, Ivanova I, Tsvetkova D (2023) Creatine lysinate – part I: investigation of the toxicity and the influence on some biochemical parameters in mice. Pharmacia 70(4): 895-899. https://doi.org/10.3897/pharmacia.70.e109446

28. COST-EFFECTIVENESS OF DISEASE-MODIFYING TREATMENTS FOR MULTIPLE SCLEROSIS IN BULGARIA BASED ON EVIDENCE FROM REAL WORLD SETTINGS.

29. UHPLC-Orbitrap screening of oleraindoles in hydromethanolic extracts of Portulaca oleracea.

30. Metabolic syndrome: comparison of three diet-induced experimental models.

37. Мениджмънт на здравните грижи при пациенти с артериална хипертония

41. Exploration of collagenase, cyclooxigenases, angiogenesis and free radical processes as the putative pharmacological targets of Arum maculatum L.

43. Last N

Catalog

Books, media, physical & digital resources